Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Dianthus Therapeutics Inc...

    NASDAQ: DNTH · Real-Time Price · USD
    18.83
    0.26 (1.40%)
    At close: Jun 06, 2025, 3:59 PM
    18.85
    0.11%
    After-hours: Jun 06, 2025, 04:20 PM EDT

    Dianthus Therapeutics Statistics

    Share Statistics

    Dianthus Therapeutics has 32.16M shares outstanding. The number of shares has increased by 9.46% in one year.

    Shares Outstanding

    n/a
    		 32.16M

    Shares Change (YoY)

    n/a
    		 9.46%

    Shares Change (QoQ)

    n/a
    		 8.54%

    Owned by Institutions (%)

    n/a
    		 99.99%

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 1,475

    FTD / Avg. Volume

    n/a
    		 0.43%

    Short Selling Information

    The latest short interest is 6.37M, so 19.81% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 6.37M

    Short % of Shares Out

    n/a
    		 19.81%

    Short % of Float

    n/a
    		 24.24%

    Short Ratio (days to cover)

    n/a
    		 26.76

    Valuation Ratios

    The PE ratio is -8.78 and the forward PE ratio is -4.96. Dianthus Therapeutics's PEG ratio is 0.12.

    PE Ratio

    n/a
    		 -8.78

    Forward PE

    n/a
    		 -4.96

    PS Ratio

    n/a
    		 119.7

    Forward PS

    n/a
    		 3.1

    PB Ratio

    n/a
    		 2.12

    P/FCF Ratio

    n/a
    		 -9.53

    PEG Ratio

    n/a
    		 0.12
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Dianthus Therapeutics.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 15.22, with a Debt / Equity ratio of 0.

    Current Ratio

    n/a
    		 15.22

    Quick Ratio

    n/a
    		 15.22

    Debt / Equity

    n/a
    		 0

    Debt / EBITDA

    n/a
    		 -0.01

    Debt / FCF

    n/a
    		 -0.02

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $79,935.9

    Profits Per Employee

    n/a
    		 $-1,089,346.15

    Employee Count

    n/a
    		 78

    Asset Turnover

    n/a
    		 0.02

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -11.23% in the last 52 weeks. The beta is 1.37, so Dianthus Therapeutics's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.37

    52-Week Price Change

    n/a
    		 -11.23%

    50-Day Moving Average

    n/a
    		 19

    200-Day Moving Average

    n/a
    		 23.38

    Relative Strength Index (RSI)

    n/a
    		 47.94

    Average Volume (20 Days)

    n/a
    		 345,038

    Income Statement

    In the last 12 months, Dianthus Therapeutics had revenue of 6.24M and earned -84.97M in profits. Earnings per share was -2.48.

    Revenue

    n/a
    		 6.24M

    Gross Profit

    n/a
    		 5.82M

    Operating Income

    n/a
    		 -101.86M

    Net Income

    n/a
    		 -84.97M

    EBITDA

    n/a
    		 -101.86M

    EBIT

    n/a
    		 -101.86M

    Earnings Per Share (EPS)

    n/a
    		 -2.48
    Full Income Statement

    Balance Sheet

    The company has 22.79M in cash and 1.49M in debt, giving a net cash position of 21.3M.

    Cash & Cash Equivalents

    n/a
    		 22.79M

    Total Debt

    n/a
    		 1.49M

    Net Cash

    n/a
    		 21.3M

    Retained Earnings

    n/a
    		 -174.39M

    Total Assets

    n/a
    		 348.58M

    Working Capital

    n/a
    		 254.05M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -78.18M and capital expenditures -105K, giving a free cash flow of -78.28M.

    Operating Cash Flow

    n/a
    		 -78.18M

    Capital Expenditures

    n/a
    		 -105K

    Free Cash Flow

    n/a
    		 -78.28M

    FCF Per Share

    n/a
    		 -2.29
    Full Cash Flow Statement

    Margins

    Gross margin is 93.39%, with operating and profit margins of -1633.74% and -1362.77%.

    Gross Margin

    n/a
    		 93.39%

    Operating Margin

    n/a
    		 -1633.74%

    Pretax Margin

    n/a
    		 -1362.77%

    Profit Margin

    n/a
    		 -1362.77%

    EBITDA Margin

    n/a
    		 -1633.74%

    EBIT Margin

    n/a
    		 -1633.74%

    FCF Margin

    n/a
    		 -1255.57%

    Dividends & Yields

    DNTH does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for DNTH is $50, which is 169.1% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $50

    Price Target Difference

    n/a
    		 169.1%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 8
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Sep 12, 2023. It was a backward split with a ratio of 1:16.

    Last Split Date

    n/a
    		 Sep 12, 2023

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:16

    Scores

    Altman Z-Score

    n/a
    		 16.04

    Piotroski F-Score

    n/a
    		 1

    Add to Watchlist